Louise joined HGF in September 2018 and completed a part-time distance learning course at the University of Bournemouth in 2019, obtaining a postgraduate certificate in Intellectual Property Law.
Louise's background and qualifications are in chemistry. She graduated in 2013 with a First Class MSci honours degree in Chemistry and obtained her PhD in 2018, both from the University of Birmingham. Louise's PhD research involved the de novo design of peptide architectures for use as imaging agents.
Alongside her undergraduate studies, Louise also worked in industry, undertaking two summer placements in the Research and Development team at Scott Bader.
During her PhD she spent two months working with collaborators in San Sebastian. This work was presented at several international conferences and resulted in a number of publications.
Following the completion of her PhD, Louise completed two research fellow posts at the University of Birmingham, the first in the School of Chemistry and the second in the Institute of Microbiology and Infection. Here she explored topical treatments for age-related macular degeneration, presenting her work at the ARVO Annual Meeting in Hawaii. Alongside this project, she assisted in researching the development of smart coatings for implant materials.
MSci, Chemistry, 2013
PhD, Chemistry, 2017
PG Cert, Intellectual Property Law, 2019
Managing Intellectual Property IP Stars 2021, comprising the highly recommended IP professionals, has now been published. HGF is delighted to have 14 European attorneys listed. IP STARS is the leading …Read article
Pharmaceutical and biotechnology patent applications also make top 10 most patented. Recent statistics published by the EPO show that a total of 14,295 European patent applications were filed in 2020 …Read article
The 2021 EPO Guidelines provide much needed guidance on how to protect antibodies in Europe. Biological drugs including therapeutic antibodies have become increasingly important to the pharmaceutical industry. The European …Read article
Opportunities for additional pharmaceutical product patent protection in Europe, based on the use of a drug to treat a patient exhibiting a biomarker indicative of drug response. Recent years have …Read article
Exploring the growth of patents for connected medical devices, and how best to protect them. The Internet of Things (IoT) is expected to change our lives by creating a connected …Read article
To waive, or not to waive, that is the question. The earliest identified date of a patient presenting with symptoms of a “novel coronavirus” in Wuhan, China is reported to …Read article
HGF in Europe and Knobbe Martens in the US are holding a joint webinar on 9th June. In this webinar we will explore considerations for implementing an effective strategy to …Event details
HGF Partner Dr Susan Keston and Senior Patent Attorney Dr Sofie McPherson will be presenting a webinar ‘How to capitalise on the 5G healthcare revolution’ on 25th May. This session will explore how 5G …Event details
If you would like to discuss how HGF could help you, contact one of our IP specialists.